Centipaine for Pain Control

Centipaine for Pain Control by

Drug Labeling and Warnings

Centipaine for Pain Control by is a Otc medication manufactured, distributed, or labeled by ASCLEMED USA INC.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

CENTIPAINE FOR PAIN CONTROL- lidocaine 4%, menthol 1% patch 
ASCLEMED USA INC.

----------

Centipaine for Pain Control

Active Ingredients

Lidocaine 4%

Menthol 1%

Purpose

Topical Analgesic

Uses

For the temporary relief of pain.

Warnings

For external use only not intended for ingestion.

Do not use

  • in large quantities, particularly over raw surfaces, or blistered areas.

When using this product

  • Avoid contact with the eyes.

Stop use and ask doctor if

  • condition worsens, or if symtoms persist for more than 7 days or clear up and occur again within a few days.

Keep out of reach of children.

If swallowed, get medical help, or contact a Poison Control Central right away.

If pregnant or breast-feeding, ask a health professional before use.

Directions

  • Adults and children 2 years of age and older: Apply to affected area not more than 3 to 4 times a daily.
  • Children under 2 years of age: consult a doctor.

Other Information

Store at 20-25 oC (68-77 oF) and protect from moisture.

Inactive ingredients

polyacrylamide, vinol, sodium polyacrylate; acrylate polymerization, purified water.

Questions?

(310) 320-0100

box

CENTIPAINE FOR PAIN CONTROL 
lidocaine 4%, menthol 1% patch
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 76420-146
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MENTHOL, UNSPECIFIED FORM (UNII: L7T10EIP3A) (MENTHOL, UNSPECIFIED FORM - UNII:L7T10EIP3A) MENTHOL, UNSPECIFIED FORM1 g  in 100 g
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987) LIDOCAINE4 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
POLYACRYLAMIDE (10000 MW) (UNII: E2KR9C9V2I)  
ETHENYL (UNII: PQ2K3G3591)  
ACRYLATES CROSSPOLYMER-6 (UNII: 4GXD0Q3OS3)  
SODIUM POLYACRYLATE (2500000 MW) (UNII: 05I15JNI2J)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 76420-146-033 in 1 BOX01/19/202204/27/2024
14 g in 1 PATCH; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph Drug505G(a)(3)12/23/202104/27/2024
Labeler - ASCLEMED USA INC. (059888437)

Revised: 4/2025
 

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.